Hepatology

Management of NAFLD is not as straightforward as it first looks. There is no virus to suppress, no single behaviour to modify, no easy prescription, and no straightforward route to transplantation.

This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…

Non-alcoholic steatohepatitis (NASH) is the advanced form of non-alcoholic fatty liver disease, which can lead to further…

This paper describes a case study of the co-design and development of two new COVID-19 digital services to support the Scottish…

The natural history of patients with cirrhosis is characterised by the development of acute decompensating events…

Hepatomegaly can be a presenting or associated feature of an inherited lysosomal storage disorder. Thus, a high index of suspicion should be maintained in patients without an aetiologic diagnosis. Read more.

Non-alcoholic fatty liver disease (NAFLD) is considered as one of the fastest emerging global health priorities due to the continuous…

The benefits of rifaximin use continues to gather momentum, given its well-tolerated side-effect profile, and these require consideration.